We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Greatbatch, Inc. (NYSE:GB) and Enpath Medical, Inc. (NASDAQ:NPTH) announced today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR...
Company Earns $.05 Per Share MINNEAPOLIS, May 2 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH), a leading developer and manufacturer of proprietary products for blue-chip medical...
Greatbatch, Inc. (the ?Company?) (NYSE:GB) and Enpath Medical, Inc. (Nasdaq:NPTH) announced today that they have entered into a definitive merger agreement under which...
MINNEAPOLIS, April 20 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH) announced today that it will release its first quarter 2007 financial results at the close of market on...
Anthony Headley Named Vice President & General Manager for Leads & Catheter Products MINNEAPOLIS, April 17 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH), a leading developer and...
Enpath completes move into new 95,000 square foot facility with over 18,000 square feet of cleanroom space. MINNEAPOLIS, April 10 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH), a...
Enpath Named as Key Introducer Supplier in Contract Extension through October 2012 MINNEAPOLIS, April 5 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH), a leading developer and...
Full-year Revenue of $36.8 Million, Earnings Per Share of $0.24 MINNEAPOLIS, Feb. 22 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH), a leading developer and manufacturer of...
MINNEAPOLIS, Feb. 14 /PRNewswire-FirstCall/ -- Enpath Medical, Inc. (NASDAQ:NPTH) announced today that it will release its fourth quarter 2006 financial results at the close of market on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions